Overview / Abstract: |
This roundtable discussion includes a panel of three faculty experts, who review clinical evidence related to the use of PCSK9 inhibitors in managing hyperlipidemia. Utilizing supporting clinical data and real-world experience, the faculty discuss how gaps in patient care can be improved via increased recognition of high-risk patients, application of clinical trial data, and selection of therapies in complex patients. Treatment decisions for hyperlipidemia are increasingly challenging due to changing guidelines and a new class of therapies, the PCSK9 inhibitors. Further, clinicians must have competence in identifying high-risk patients who may require intensification or switching to a new therapy. Data from the cardiovascular outcomes trials with the PCSK9 inhibitors can assist in the identification of eligible at-risk patients. Interventional cardiologists require up-to-date knowledge of these new therapies and data since they are likely to encounter high-risk patients with hyperlipidemia. Upon completion of this activity, participants will be able to: |
Expiration |
Aug 28, 2019 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME, Surgical Technology CE |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
1.0 |
Accreditation |
ACCME |
Is This Activity Certified for "Live" Credit? |
YES |
Presenters / Authors / Faculty |
Rajesh Dave, MD, FACC, FSCAI (Moderator) Nihar Desai, MD, MPH Robert Giugliano, MD, SM |
Activity Specialities / Related Topics |
Anticoagulation / Thrombosis, Cardiology / Cardiovascular, Dyslipidemia / Cholesterol, Education / Teaching, Family Medicine, Hypertension / Blood Pressure, Internal Medicine, Podiatry, Primary Care |
Sponsors / Supporters / Grant Providers |
Sponsored by the Academy for Continued Healthcare Learning (ACHL) and the Interventional Academy. Supported by an educational grant from Amgen Inc. |
Keywords / Search Terms |
ACHL CME, CE, Continuing Medical Education, CME/CE, Online Learning, Webcasts, Newsletter, Case Study, Live Meetings, Slidekit, Monograph, Journal, Cardiology, interventional cardiology, PCSK9, hyperlipidemia, Interventional Academy, C3 2018, Amgen, FOURIER, ODYSSEY, Dave, Giugliano, Desai, LDL-C, HDL-C, blood cholesterol, evolocumab, alirocumab, Raj Dave, Dave, Robert Giugliano, Giugliano, Nihar Desai, Desai Free CE CME Live CE CME |